NPI Portal NPI Lookup & Verification

Type 2 · Organization ✓ Active NPI ✓ Valid NPI checksum

Adaptive Biotechnologies Corporation

Clinical Medical Laboratory in Seattle, WA · enumerated 2013 · authorized official Chad Robins, Ceo, President, Co-Founder.

Data current as of Jul 13, 2026 · sourced from CMS NPPES

National Provider Identifier

1508105024

Verified

See something wrong? Report a correction

Registry record

Entity type Organization (Type 2)
Legal business name Adaptive Biotechnologies Corporation
Practice address 1165 Eastlake Ave E, Seattle, WA, 98109
Fax (206) 299-0488
Enumeration date Feb 4, 2013
Last updated in NPPES Mar 31, 2025

Taxonomy & classification

291U00000X Clinical Medical Laboratory Laboratories · License 50D2046518 (WA) Primary

Authorized official

Name Chad Robins
Title Ceo, President, Co-Founder

What is an NPI number?

A National Provider Identifier (NPI) is a unique 10-digit number that CMS assigns to every U.S. healthcare provider and organization under HIPAA. Type 1 NPIs identify individual providers; Type 2 NPIs identify organizations. The NPI appears on insurance claims, prescriptions, and credentialing paperwork, and never changes, even if the provider moves or changes specialty.

Read the full guide → Validate an NPI →

Frequently asked questions

What is the NPI number for Adaptive Biotechnologies Corporation?
The NPI for Adaptive Biotechnologies Corporation is 1508105024, a Type 2 (organization) record in the CMS NPPES registry.
Who is the authorized official for Adaptive Biotechnologies Corporation?
NPPES lists Chad Robins (Ceo, President, Co-Founder) as the authorized official for this organization.

Providers at this address

Browse all →

Source: CMS NPPES (public data). Snapshot 2026-07-13. Provider record last updated 2025-03-31.